tiprankstipranks
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR

Marker Therapeutics (MRKR) Ownership - Who Owns Marker Therapeutics?

479 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 08, 2023
David Eansor
Director
Bought$249988

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,068,043Insider68.16%26,699,389
5,300,002Insider59.53%23,320,009
2,394,535Insider26.90%10,535,954
314,286Institution3.53%1,382,858
230,719Institution2.59%1,015,164
222,545Institution2.50%979,198
189,337Insider2.13%833,083
179,711Insider2.02%790,728
170,554Insider1.92%750,438
54,438Institution0.61%239,527

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
222,545Institution2.50%979,198
54,438Institution0.61%239,527
15,900Institution0.18%69,960
820Institution<0.01%3,608
697Institution<0.01%3,067
462Institution<0.01%2,034

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Marker Therapeutics Inc (MRKR)?
Currently, no data Available
What percentage of Marker Therapeutics Inc (MRKR) stock is held by institutional investors?
Currently, no data Available
What percentage of Marker Therapeutics Inc (MRKR) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Marker Therapeutics Inc (MRKR)?
John Robert Wilson owns the most shares of Marker Therapeutics Inc (MRKR).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis